Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 15,882,655
- Share change
- -75,465
- Total reported value
- $90,121,602
- Price per share
- $5.68
- Number of holders
- 34
- Value change
- -$464,823
- Number of buys
- 11
- Number of sells
- 12
Report period
Q1 2022
Institutions
34
Top holders
10
SCPH full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 810648105
Recent filing periods:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
9%
|
4,797,148
|
$24,082,000 | — | 31 Dec 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
7.2%
|
3,831,474
|
$19,234,000 | — | 31 Dec 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5%
|
2,691,770
|
$13,513,000 | — | 31 Dec 2021 | |
| AIGH Capital Management LLC |
13F
|
Company |
2.6%
|
1,373,124
|
$6,893,000 | — | 31 Dec 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.7%
|
901,362
|
$4,525,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
616,558
|
$3,095,000 | — | 31 Dec 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.69%
|
370,091
|
$1,858,000 | — | 31 Dec 2021 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.62%
|
332,647
|
$1,670,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
188,986
|
$949,000 | — | 31 Dec 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
132,200
|
$664,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.18%
|
96,747
|
$485,000 | — | 31 Dec 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
86,635
|
$435,000 | — | 31 Dec 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.15%
|
81,891
|
$411,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
74,804
|
$375,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
71,209
|
$357,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.11%
|
59,466
|
$298,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
49,710
|
$249,000 | — | 31 Dec 2021 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.07%
|
36,989
|
$186,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
34,603
|
$173,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
33,338
|
$167,000 | — | 31 Dec 2021 | |
| Thomasville National Bank |
13F
|
Company |
0.03%
|
15,000
|
$75,000 | — | 31 Dec 2021 | |
| IPG Investment Advisors LLC |
13F
|
Company |
0.03%
|
14,300
|
$72,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
14,000
|
$70,000 | — | 31 Dec 2021 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
12,882
|
$65,000 | — | 31 Dec 2021 | |
| Sandy Cove Advisors, LLC |
13F
|
Company |
0.02%
|
10,592
|
$53,000 | — | 31 Dec 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
3,907
|
$20,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,253
|
$11,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,172
|
$6,000 | — | 31 Dec 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
539
|
$2,000 | — | 31 Dec 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
383
|
$1,923 | — | 31 Dec 2021 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q1 2022
As of 31 Mar 2022,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,882,655 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., AIGH Capital Management LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, Belvedere Trading LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
29
Q1 2022 holders
34
Holder diff
5
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.